Licensing agreements in cancer research are legal contracts that grant one party the rights to use another party's intellectual property, such as patents, drug formulations, or proprietary technology. These agreements are essential for the commercialization of cancer treatments, as they provide the framework for collaboration between the entities that own the intellectual property and those that can bring it to market.
